FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

714434001: Product containing cilastatin and imipenem in parenteral dose form (medicinal product form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3709193015 Cilastatin- and imipenem-containing product in parenteral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3709194014 Product containing cilastatin and imipenem in parenteral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5472981000241111 produit contenant de la cilastatine et de l'imipénem sous forme parentérale fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

8 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cilastatin- and imipenem-containing product in parenteral dose form Is a Product containing cilastatin and imipenem (medicinal product) true Inferred relationship Some
Cilastatin- and imipenem-containing product in parenteral dose form Is a Product manufactured as parenteral dose form (product) true Inferred relationship Some
Cilastatin- and imipenem-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Imipenem true Inferred relationship Some 1
Cilastatin- and imipenem-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Cilastatin true Inferred relationship Some 2
Cilastatin- and imipenem-containing product in parenteral dose form Has manufactured dose form Parenteral dose form (dose form) true Inferred relationship Some
Cilastatin- and imipenem-containing product in parenteral dose form Plays role Antibacterial therapeutic role (role) false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Imipenem 500mg/cilastatin 500mg powder for infusion solution vial Is a False Cilastatin- and imipenem-containing product in parenteral dose form Inferred relationship Some
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Is a False Cilastatin- and imipenem-containing product in parenteral dose form Inferred relationship Some
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial Is a False Cilastatin- and imipenem-containing product in parenteral dose form Inferred relationship Some
Imipenem 750mg/cilastatin 750mg powder for injection solution vial Is a False Cilastatin- and imipenem-containing product in parenteral dose form Inferred relationship Some
Product containing only cilastatin and imipenem in parenteral dose form (medicinal product form) Is a True Cilastatin- and imipenem-containing product in parenteral dose form Inferred relationship Some
Product containing cilastatin and imipenem and relebactam in parenteral dose form (medicinal product form) Is a True Cilastatin- and imipenem-containing product in parenteral dose form Inferred relationship Some

This concept is not in any reference sets

Back to Start